Philippines Progesterone Market Analysis

Philippines Progesterone Market Analysis


$ 3999

Philippines Progesterone Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Progesterone market is growing globally due to the increasing prevalence of breast cancer which require progesterone and it’s based drugs, growth of geriatric population, growing prevalence of uterine bleeding and amenorrhea, rise in infertility treatment in women, uterine death, availability of frequently monitored formulations, technical developments in drug delivery systems, more patient awareness drive the demand for progesterone. Increased financing initiatives, the expanding trend of home healthcare and infrastructure development in the healthcare industry. Merck & Co., Inc., Pfizer Inc., Bayer AG, AbbVie Inc., Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Novartis AG, Mylan N.V., Allergan plc, Amgen Inc., Lupin Pharmaceuticals, Inc., and Sun Pharmaceutical Industries Ltd. are the key global market players in progesterone market.

ID: IN10PHPH383 CATEGORY: Pharmaceuticals GEOGRAPHY: Phillipines AUTHOR: Dr. Netal Patel

Buy Now

Philippines Progesterone Market Analysis Summary

Philippines Progesterone Market is valued at around $2.6 Mn in 2022 and is projected to reach $6.7 Mn by 2030, exhibiting a CAGR of 12.83% during the forecast period 2023-2030.

The adrenal medulla, ovary, and placenta all naturally create the steroid hormone known as progesterone. Progesterone primarily affects embryogenesis, menstrual cycle management, and pregnancy maintenance. Low progesterone levels can cause exhaustion, continuous breast soreness, stomach ache, miscarriage, or even fetal death. Progesterone is administered to the patient during this phase to stop the aforementioned symptoms. Natural progesterone is expected to rise at a healthy rate. Natural progesterone-based solutions are the most effective in terms of generating prescriptions. The most significant income sources are drugs like Crinone and Prometrium. Synthetic progesterone or progestins are also employed as a diagnostic tool to examine the effects of estrogen due to technical developments in the medical industry. Progesterone is used in a variety of ways. In Hormone Replacement Therapy, it's used with estrogen. It's also utilized in the treatment of female infertility. Merck & Co., Inc., Pfizer Inc., Bayer AG, AbbVie Inc., Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Novartis AG, Mylan N.V., Allergan plc, Amgen Inc., Lupin Pharmaceuticals, Inc., and Sun Pharmaceutical Industries Ltd. are the key global market players in progesterone market.

Market Dynamics

Market Growth Drivers

The increasing prevalence of breast cancer which requires progesterone and its based drugs, growth of the geriatric population globally, growing prevalence of uterine bleeding and amenorrhea, rise of infertility treatment in women, uterine death, availability of frequently monitored formulations, technical developments in drug delivery systems, increase in patient awareness. Increased financing initiatives, the expanding trend of home healthcare, and infrastructure development in the healthcare industry. All these factors act as market growth drivers.


Market Restraints

Lack of awareness about progesterone therapy's availability and the therapy's adverse effects like breast discomfort, fever, joint aches, headache, dizziness, breast lumps, impaired vision, sudden vaginal bleeding, severe convulsions, constipation, nausea, and hair loss. All these factors act as market growth restraints.

Competitive Landscape

Key Players

  • Merck & Co., Inc.
  • Pfizer Inc.
  • Bayer AG
  • AbbVie Inc.
  • Johnson & Johnson
  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG
  • Mylan N.V.
  • Allergan plc
  • Amgen Inc.
  • Lupin Pharmaceuticals, Inc.
  • Sun Pharmaceutical Industries Ltd.

Notable deals in Philippines Progesterone Market

In October 2022, the Subject Expert Committee (SEC), a unit of the Central Drug Standard Control Organization (CDSCO), gave Sun Pharma permission to produce and sell progesterone sustained-release tablets (200/300/400mg) in India.

In September 2021, Theramex introduced Bijuva/Bijuve (1 mg estradiol/100 mg progesterone) in Europe and the UK. For post-menopausal women with an intact uterus, bijuva is one of the body-identical hormone therapy medications used to treat symptoms of estrogen insufficiency.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Market Segmentations For Philippines Progesterone Market

By Product Type

  • Natural
  • Synthetic Progesterone

By Mode of Delivery

  • Injectable
  • Suspended form
  • Oral
  • Other Modes of Delivery

By Application

  • Menopause
  • Dysfunctional Uterine Bleeding
  • Endometrial Cancer
  • Contraception
  • Hyperplastic Precursor Lesions
  • Other Applications

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.​

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

  • Analyzing historical proprietary data collected from multiple projects.
  • Regularly updating our existing data sets with new findings and trends.
  • Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

  • Searching through academic conferences, published research, citations, and social media platforms
  • Collecting and compiling diverse data to build a comprehensive and detailed database
  • Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

  • Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
  • Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
  • Continuously refreshing our database to ensure that the information remains current and reliable.
  • Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

  • Merging historical data from secondary research with real-time data from primary research.
  • Conducting thorough data validation and cleansing to remove inconsistencies and errors.
  • Organizing data into a structured format that is easily accessible and usable for various applications.
  • Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


Last updated on: 27 February 2024
Updated by: Dr. Purav Gandhi

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up